ADVERUM BIOTECHNOLOGIES INC's ticker is and the CUSIP is 00773U958. A total of 1 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $0 | -100.0% | 400 | -99.2% | 0.00% | – |
| Q1 2022 | $64,000 | -79.0% | 49,500 | -71.5% | 0.00% | – |
| Q4 2021 | $305,000 | -46.8% | 173,600 | +9.0% | 0.00% | -100.0% |
| Q3 2021 | $573,000 | +2.9% | 159,300 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $557,000 | -64.9% | 159,300 | +9794.4% | 0.00% | -66.7% |
| Q1 2021 | $1,587,000 | +1200.8% | 1,610 | +1324.8% | 0.00% | – |
| Q4 2020 | $122,000 | +69.4% | 113 | +61.4% | 0.00% | – |
| Q3 2020 | $72,000 | -62.9% | 70 | -24.7% | 0.00% | – |
| Q2 2020 | $194,000 | +41.6% | 93 | -34.0% | 0.00% | – |
| Q1 2020 | $137,000 | +11.4% | 141 | +31.8% | 0.00% | – |
| Q4 2019 | $123,000 | +11.8% | 107 | -47.3% | 0.00% | – |
| Q3 2019 | $110,000 | +2100.0% | 203 | +3960.0% | 0.00% | – |
| Q2 2019 | $5,000 | +66.7% | 5 | -16.7% | 0.00% | – |
| Q1 2019 | $3,000 | -93.3% | 6 | -95.9% | 0.00% | – |
| Q4 2018 | $45,000 | +275.0% | 146 | +595.2% | 0.00% | – |
| Q3 2018 | $12,000 | – | 21 | +2000.0% | 0.00% | – |
| Q2 2018 | $0 | -100.0% | 1 | -94.4% | 0.00% | – |
| Q1 2018 | $3,000 | – | 18 | +1700.0% | 0.00% | – |
| Q4 2017 | $0 | – | 1 | -90.0% | 0.00% | – |
| Q3 2017 | $0 | – | 10 | 0.0% | 0.00% | – |
| Q2 2017 | $0 | -100.0% | 10 | -9.1% | 0.00% | – |
| Q4 2016 | $1,000 | -91.7% | 11 | -81.4% | 0.00% | -100.0% |
| Q3 2016 | $12,000 | -60.0% | 59 | -59.9% | 0.00% | -50.0% |
| Q2 2016 | $30,000 | – | 147 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |